Cargando…
Human ES cell-derived dendritic cells: Meeting the challenge of immune rejection in allogeneic cell therapy
Autor principal: | Zenke, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701318/ https://www.ncbi.nlm.nih.gov/pubmed/33254028 http://dx.doi.org/10.1016/j.ebiom.2020.103144 |
Ejemplares similares
-
The Progression of Cell Death Affects the Rejection of Allogeneic Tumors in Immune-Competent Mice – Implications for Cancer Therapy
por: Chaurio, Ricardo A., et al.
Publicado: (2014) -
Dendritic cell cross‐dressing and tumor immunity
por: Martinez‐Usatorre, Amaia, et al.
Publicado: (2022) -
Mesenchymal stem cells avoid allogeneic rejection
por: Ryan, Jennifer M, et al.
Publicado: (2005) -
Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection?
por: Mubarak, M.
Publicado: (2016) -
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
por: Schuler, G., et al.
Publicado: (1997)